AI assistant
Sending…
LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2011
Mar 25, 2011
32814_dirs_2011-03-25_6bde8f35-d744-42da-afe2-c3638cd232b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEXICON PHARMACEUTICALS, INC./DE (LXRX)
CIK: 0001062822
Period of Report: 2011-03-23
Reporting Person: Lapuerta Pablo (SVP, Clin Dev and CMO)